Duration of antimicrobial therapy for nosocomial pneumonia: possible strategies for minimizing antimicrobial use in intensive care units

被引:8
|
作者
Dugan, HA [1 ]
MacLaren, R [1 ]
Jung, R [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Pharm Practice, Denver, CO 80262 USA
关键词
duration of antibiotic therapy; nosocomial pneumonia; shorter course;
D O I
10.1046/j.1365-2710.2003.00471.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To review published data evaluating shorter courses of antibiotic therapy for nosocomial pneumonia and provide recommendations for minimizing antimicrobial use in intensive care units. Data source: Literature was identified through MEDLINE (1966 through 6/2002) and a manual search of critical care, infectious disease, and pharmacy journals was conducted to identify relevant abstracts. Data synthesis: Antibiotic use may be decreased by discontinuing therapy after 3 days in patients with low likelihood of nosocomial pneumonia. In addition, clinical guidelines or invasive diagnostic procedures may be effectively instituted to reduce duration of antibiotic therapy. Conclusion: Shorter-course antibiotic therapy may be beneficial in decreasing lengths of hospital and intensive care units stays, antimicrobial resistance, and total hospital costs. Further research is needed to determine the optimal duration of therapy in patients with nosocomial pneumonia.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 50 条
  • [21] MRSA and antimicrobial use in German intensive care units:: Data from the Surveillance system of Antimicrobial Use and Antimicrobial Resistance (SARI)
    Elisabeth, M
    Jonas, D
    Schwab, F
    Rüden, H
    Gastmeier, P
    Daschner, F
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 294 : 113 - 113
  • [22] Antimicrobial use and antimicrobial resistance in German Intensive Care Units (SARI), 2001-2004
    Meyer, E.
    Schwab, F.
    Gastmeier, P.
    Rueden, H.
    Daschner, F.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 296 : 154 - 155
  • [23] Nosocomial pneumonia: impact of a very early antimicrobial therapy
    L Montesino
    C Cazenave
    X Jeusset
    P Remi
    M Thyrault
    J Coudray
    Critical Care, 9 (Suppl 1):
  • [24] Stenotrophomonas maltophilia and antibiotic use in German intensive care units:: data from project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units)
    Meyer, E.
    Schwab, F.
    Gastmeier, P.
    Rueden, H.
    Daschner, F. D.
    Jonas, D.
    JOURNAL OF HOSPITAL INFECTION, 2006, 64 (03) : 238 - 243
  • [25] Nosocomial pneumonia: Current etiology and impact on antimicrobial therapy
    Javier Gamazo, Julio
    Javier Candel, Francisco
    Gonzalez del Castillo, Juan
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2023, 36 : 9 - 14
  • [26] A nationwide survey of intravenous antimicrobial use in intensive care units in Japan
    Ohnuma, Tetsu
    Hayashi, Yoshiro
    Yamashita, Kazuto
    Marquess, John
    Lefor, Alan Kawarai
    Sanui, Masamitsu
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (04) : 636 - 641
  • [27] Evaluation of Nosocomial Infections and Antimicrobial Resistance Profiles in the Intensive Care Units: Nine Years Experience
    Keskin Seremet, Aysegul
    Kizilates, Filiz
    Demir Onder, Kubra
    Oztoprak, Nefise
    BEZMIALEM SCIENCE, 2020, 8 (04): : 330 - 337
  • [28] Overall antimicrobial use and control strategies in intensive care units from 6 European countries.
    Monnet, DL
    Suetens, C
    Jepsen, OB
    Burman, LG
    Carsauw, H
    Gastmeier, P
    Jurkuvenas, V
    Sainz, A
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2000, 21 (02): : 88 - 88
  • [29] Managing antimicrobial resistance in intensive care units
    Gandhi, Tejal N.
    DePestel, Daryl D.
    Collins, Curtis D.
    Nagel, Jerod
    Washer, Laraine L.
    CRITICAL CARE MEDICINE, 2010, 38 (08) : S315 - S323
  • [30] Antimicrobial stewardship of β-lactams in intensive care units
    Cotta, Menino Osbert
    Roberts, Jason A.
    Tabah, Alexis
    Lipman, Jeffrey
    Vogelaers, Dirk
    Blot, Stijn
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2014, 12 (05) : 581 - 595